anmelden
AstraZeneca Aktie
147,60
EUR
-0,75
EUR
-0,51
%
146,75
EUR
-1,20
EUR
-0,81
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 02.04.19 | AstraZeneca Sell | UBS AG | |
| 02.04.19 | AstraZeneca Reduce | HSBC | |
| 01.04.19 | AstraZeneca overweight | Barclays Capital | |
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.03.19 | AstraZeneca overweight | Barclays Capital | |
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 29.03.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
| 28.02.19 | AstraZeneca Reduce | HSBC | |
| 26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.02.19 | AstraZeneca overweight | Barclays Capital | |
| 25.02.19 | AstraZeneca overweight | Barclays Capital | |
| 18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.02.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.12.18 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 11.12.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.11.18 | AstraZeneca Reduce | HSBC | |
| 19.11.18 | AstraZeneca Neutral | UBS AG | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca Reduce | HSBC | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca Hold | CFRA | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital | |
| 08.11.18 | AstraZeneca Neutral | UBS AG | |
| 08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 19.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.10.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.10.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
Werbung
Werbung